REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer

Authors:

Abstract
No abstract available
Funding Information
  • Ovarian Cancer Research Foundation
  • Cancer Australia (1050134, 1067589)

This publication has 26 references indexed in Scilit: